Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21)
Funds the exploratory version of the same work on screening tests and treatments for serious newborn conditions.
A condition gets added to a newborn screening panel when two things are true: there is an accurate test for it, and finding it early demonstrably helps. This notice funds building either half.
Two kinds of work are in scope. Novel screening approaches, and therapeutic interventions, for potentially fatal or disabling conditions.
Two kinds of condition qualify. Those already identified through ne…
Development of novel screening approaches and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening, and for high priority genetic conditions where screening is not currently recommended but infants would significantly benefit from early identification and treatment. Clinical trials are optional.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up